The new 7-bromoindirubin-3'-oxime (7BIO) compound induces caspase-independent cell death in all cell lines tested to date. Irrespective of the cell line, a 25 µM treatment for 24 hours is lethal for the entire cell population. In SH-SY5Y and Jurkat cells, 7BIO (25 µM) was found to collapse the mitochondrial transmembrane potential (∆Ψm) at only 2-3 hours of treatment. Concomitantly mitochondria swelled, cristae disrupted and, after 9 hours, external cell membranes ruptured. In addition, endoplasmic reticulum dilated and, unexpectedly, the acute cytoplasmic destruction yielded isolated nuclei with preserved morphology and DNA integrity. Furthermore, the process was independent of both Bax and Bak, since cell viability and ∆Ψm decayed indistinguishably in double Bax-/-Bak-/-mouse embryonic fibroblasts (MEFs) and their wild type counterparts. Pharmacological inhibition of the mitochondrial permeability transition pore (MPTP) did not prevent 7BIO-induced ∆Ψm loss in none of the aforementioned cell lines. Caspase-independent inducers of cell death like AIF (Apoptosis Inducing Factor), cathepsins and calpains were not involved. Only the chemical inhibitors of serine proteases and, particularly, AEBSF afforded a significant protection thus suggesting a process regulated by this type of enzymes. As far as we know, these features are quite unique once taken together. Therefore we propose 7BIO is triggering a specific type of necrotic cell death. Finally, the cytotoxicity of 7BIO on apoptosis-resistant cells like double Bax-/-Bak-/-MEFs seems of great interest envisaging cancer therapy. 
Introduction
Cell necrobiology has been proposed to be the scientific discipline devoted to the study of the biological processes which predispose, precede or accompany cell death, as well as the consequences of cell demise for the tissue environment [1] . The impressive development of apoptosis research in the last 15 years has masked the lack of knowledge about the processes involved in other types of cell death. Electron microscopy studies of embryonic models provided the first hint about the existence of other types of programmed cell death [2] . In 2005, a Nomenclature Committee on Cell Death was created and established an official classification [3] . This classification was based on morphological features and was further complemented by other criteria, like the catabolic enzymes activated in each type of cell death [4] .
Apoptosis (Type 1 cell death) and the pathways leading to it remain the most studied subject in cell necrobiology. Apoptosis is a complex phenotype of cell death. It results from caspase degradation of specific substrates. However, the lack of caspase activation does not necessarily preclude cell death or apoptosis. For instance, MCF-7, a human cell line derived from a breast cancer displaying a null expression of effector caspase 3, undergoes apoptosis facing typical apoptotic stimuli but with a non-apoptotic, atypical phenotype [5] . Autophagy (Type 2 cell death) has only recently entered and broadened the field of cell death. However, in addition to its killing role, autophagy is also a mechanism of survival for cells facing conditions such as starvation or hormone deprivation [6] . The resulting ambiguity is not an issue easy to solve and has prompted the proposal to define autophagic cell death as any death process with autophagic features but not necessarily autophagy being the cause of cell death [3] . Finally, necrosis (Type 3 cell death) and mitotic catastrophe ended the official classification [3, 4] . Necrosis has become a synonym of acute or accidental type of cell death. In other words, a scenario of cell homeostasis overwhelmed by one stressing stimulus or a combination of them. However, necrosis has also been observed to occur in a less acute and molecularly regulated way [7] [8] [9] [10] Therefore, necrosis is presently an ill-defined term. 4 Upon the discovery of the anti-leukemia properties of the indirubins contained in a traditional Chinese recipe, Danggui Longhui Wan [11] , the synthesis and study of these compounds has become an active research area. Several protein kinases have been identified as targets of indirubins: CDKs [12] , GSK-3 [13] and others [14] . The bis-indole chemistry of indirubins provides a kinase inhibitor scaffold susceptible to chemical modification. As a consequence, new indirubin derivatives can be generated in order to obtain more selective or biologically interesting compounds. Several bromo-substituted indirubin-3'-oxime derivatives were synthesized and their inhibition profile on 85 protein kinases determined [14] . In this study, 7BIO proved to be fast and effective at inducing cell death in SH-SY5Y, a human neuroblastoma-derived cell line. In addition, the cell death process did not display any of the typical features of apoptosis. For example, the internuclesosomal DNA degradation, the nuclear pattern of chromatin condensation or the release of cytochrome c from mitochondria, were not observed. Consistently, no activation of effector caspases was detected and neither Bcl-2 nor Bcl-XL overexpression afforded any protection to cells treated with 7BIO. The caspase-independent process of cell death was also detected in other human cell lines, like neuroblastic IMR-5 and IMR-32, hematological HL-60 and Jurkat, etc.
In the present report, our purpose has been to progress in the characterization of the cell death process triggered by 7BIO. We have demonstrated 7BIO induces a necrotic type of cell death characterized by early mitochondrial swelling and further cytoplasm disintegration. The involvement of proteins like calpains, cathepsins, Bax, Bak and AIF (Apoptosis Inducing Factor) has been discarded. Moreover, pharmacological inhibitors of the mitochondrial permeability transition pore (MPTP) have failed to prevent 7BIO-induced cell death and the early loss of mitochondrial transmembrane potential (∆Ψm). Finally, a pharmacological screening has suggested serine proteases could be regulating the death process. 
Materials and Methods

Chemical reagents
CellTiter 96® kit containing the MTS reagent and Cytotox 96® kit for LDH determinations were provided by Promega Biotech Ibérica, SL (Barcelona, Spain). 5BIO (5-bromoindirubin-3'-oxime) and 7BIO (7- bromoindirubin-3'-oxime) compounds were synthesized in Prof. Skaltsounis' laboratory, University of were supplied by Sigma (Saint Louis, MO, USA). Unless otherwise stated, the non-listed reagents were also from Sigma.
Cell culture and chemical treatments
SH-SY5Y is a cell line derived from the metastasis of a human neuroblastoma. Jurkat, clone E6-1, is a human cell line derived from an acute T cell leukemia. Both cell lines were obtained from ATCC (Manassas, VA, USA). The immortalized mouse embryonic fibroblasts (MEFs) derived from double Bax-/-Bak-/-null mice and their wild type (w.t.) counterparts were gently provided by Dr. S.J. Korsmeyer laboratory [15, 16] .
MEFs and SH-SY5Y cell lines were grown in 2 mM L-glutamine supplemented DMEM media plus antibiotics 6 and a 10% volume of FCS (Invitrogen, Barcelona, Spain). Jurkat cells were grown in RPMI 1640 media plus 10% FCS and antibiotics (Invitrogen, Barcelona, Spain). General culturing conditions were 37ºC and a water-saturated, 5% CO2 atmosphere. Plates with 6 (M6), 24 (M24) and 96 (M96) wells were used in our pharmacological and biochemical determinations. Plates, dishes and other plastic disposable tools for cell cultures were supplied by Iwaki (Chiba, Japan), Sarstedt (Newton, NC, USA), Bibby Sterilin (Staffordshire, UK) and Becton Dickinson (Franklin Lakes, NJ, USA). 7BIO and 5BIO were dissolved in DMSO at a concentration 10 mM. In order to improve 7BIO and 5BIO solubility, stock solutions were heated for 15 minutes at 60ºC in a sonication bath, previous to their final addition to the culture media. Stock solutions of STS, Q-VD-OPh or the other compounds were also prepared with DMSO. From these stock solutions, the compounds were delivered to the culture media and adjusted to the final concentrations reported in the text and figures. The serial dilution procedure was used in concentration-dependency determinations. DMSO concentrations never surpassed 1% in the medium. At this concentration, we have observed no alteration in cell viability or differentiation status [17] . 
Flow cytometry
Quantification of cell death
Four alternative procedures were performed in order to quantify the ratios of cell death in the culture plates.
The first one was based on the Trypan Blue dye, which enters and stains those cells with a disrupted external membrane. SH-SY5Y cells were preferentially subjected to this procedure along this report. On the other hand, in non-adherent Jurkat cells, staining with PI (25 µg/ml) and flow cytometry was chosen to detect and quantify the cells with breaches at the cell membrane. In MEFs and some pharmacological screenings we relied on the MTS reduction and the LDH release procedures, which we have described in detail before [17] .
Apoptosis assessment and quantification
We have used several independent methods to assess and quantify apoptosis in the cell cultures. First, nuclear morphology as evidenced by direct 0.05 µg/ml bisBenzimide (Hoechst 33342) staining and fluorescence microscopy. Frequently, a double staining with bisBenzimide/PI was performed. In this case, PI concentration was 25 µg/ml like above. Second, the generation of large DNA fragments of approximately 50kbp. This event was evidenced by means of agarose gels run in a contour homogeneous electric field (CHEF) system (BioRad, Hercules, CA, USA). The running conditions were 15 hours, at 6 V/cm, initial switching time of 50 seconds and final switching time of 90 seconds. Third, the detection of the ladder pattern of DNA degradation was done by a standard electrophoresis in 1.5% agarose gels. Fourth, the activity of DEVD targeted caspases. The procedure employed was based on reading the fluorescence released from an AcDEVDafc substrate after its direct addition to the culture medium, detergent cell lysis and incubation at 37°C. All these procedures have been validated and described in our previous works [14, 17, 18] . 
Electron microscopy
Cells from treated or untreated cultures were collected, washed twice in PBS (150 mM ClNa, 2.7 mM ClK, 8 mM Na2HPO4, 1.5 mM KH2PO4) and fixed for 30 minutes at 4°C in 100 mM phosphate buffer (pH 7.4) containing 2.5% glutaraldehyde. After rinsing the pellets twice with PBS at 4°C, cells were postfixed in buffered OsO4, dehydrated in graded acetone and embedded in Durcupan® ACM resin (Fluka, Buchs, Switzerland). Ultrathin sections mounted on copper grids were counterstained with uranyl acetate and lead citrate. A transmission electron microscope (Zeiss EM 910) was employed to visualize the cellular ultrastructure. 
Quantification of mitochondrial ∆Ψm
Protein extraction and Western Blotting
To study the release of AIF from mitochondria, a 0.05% digitonin cytosolic extraction (Cyt.) was performed as we have reported before [17] . The remaining pellet was the mitochondrial containing fraction (Mit.) and contained other cells constituents like nuclei. This fraction was subjected to lysis in a buffer containing 100 mM Tris/ClH pH6.8, 2%SDS, 1 mM EDTA, 1 mM PMSF, 2 µg/ml Aprotinin, 1 µg/ml Leupeptin and 1 µg/ml 
Calpain and cathepsin activity determinations
Control, untreated, or treated cells were harvested and extracted with a buffer containing 20 mM Tris/ClH pH 7.5, 150 mM NaCl, 1% Triton-X-100, 1 mM DTT and 1 mM AEBSF for 10 minutes on ice. After a centrifugation at 12000 g for 15 minutes, protein was quantified in the supernatants as previously described (DC Protein Assay, BioRad). Equal amounts of protein (20µg) were delivered to the wells of a M96 plate. 
Results
Non-apoptotic, necrotic-like features were found in the cell death process triggered by 7BIO
In our previous characterization of several indirubin derivatives, we have demonstrated that two related compounds 5-bromoindirubin-3'-oxime (5BIO) and 7BIO behaved quite differently at inducing cell death.
While the former was a caspase-dependent, apoptosis inducer, the latter triggered a caspase-independent type of death. Both compounds caused cell-death in a concentration-dependent manner. Irrespective of the cell line, after 24 hours of treatment, LC50 and LC100 neared 12.5 µM and 25 µM for 7BIO, respectively. On the other hand, 5BIO (25 µM) caused death in approximately the 60% of SH-SY5Y cells treated for 24
hours [14] . In the present work we have focused more on the time course of the cell death caused by these compounds. For instance, we characterized the kinetics of caspase activation. As shown, 5BIO (25 µM) displayed a clear time-dependent activation of DEVD-targeting caspases, while 7BIO (25 µM) yielded values repeatedly beneath those of control cells (Fig. 1A) . Consistently, Q-VD-Oph (10 µM), a chemical inhibitor of caspases characterized by its broad spectrum and selectivity for caspase inhibition was not modifying the aspect of nuclei in the cells challenged with 7BIO (Fig. 1B) . Following a double staining with bisBenzimide/PI, fluorescence microscopy showed 7BIO caused the nuclei to have a slightly condensed look irrespective of Q-VD-Oph presence. Nuclei became also globular because cells were detached from the cultures plates. The caspase-inhibiting activity of Q-VD-Oph was certified by the blockage of the apoptotic phenotype observed in 5BIO-treated SH-SY5Y cells (Fig. 1B) . Finally, the bisBenzimide/PI staining allowed the counting of apoptotic nuclei. As shown, the percentage increased in a time dependentmanner in 5BIO-treated SH-SY5Y cells. On the opposite, the ratios never surpassed those of untreated, time 0, in 7BIO-treated cells (Fig. 1C) . In conclusion, for further experiments 5BIO was used to induce apoptosis as the closest relative of 7BIO. However, cell death by 7BIO became the subject of our research.
Electron microscopy was the first approach to gain insight into the type of cell death triggered by 7BIO. For this purpose, SH-SY5Y cells were fixed and studied at different times following a treatment with 11 25 µM 7BIO. Control untreated cells displayed a rounded morphology with a large nucleus containing a diffuse euchromatin and, often, two ostensible nucleoli ( Fig. 2A) . In the cytoplasm, endoplasmic reticulum was poorly developed and an enlarged Golgi apparatus was frequently seen. Mitochondria displayed discernible cristae (Fig. 2C) . Following a 3 hours treatment, the most prominent trait was endoplasmic reticulum dilation. Interestingly, nuclear envelop was generally spared from dilating (Fig. 2B ). Mitochondria were also damaged displaying a swelled look and disrupted cristae. Small, medium and large size dilations of the reticulum could be observed and regarded as progressive phases of injury. Similarly, different stages of mitochondrial cristae disruption could be seen in a cell (Fig. 2D ). By 9 hours of treatment, we were surprised to realize cytoplasm had disintegrated and most cells converted into isolated nuclei (Fig. 2E) . In spite of the complete cytoplasm destruction, nuclear integrity was remarkable. At 9 hours or later times, a minor proportion of cells could be still observed retaining the cytoplasm. Interestingly, in these cells, autophagic multi-lamellar structures were persistently found (Fig. 2F ).
Jurkat cells were chosen, as a second cell line to investigate 7BIO mode of action, mainly because of their non-adherent growth in culture and the subsequent simplicity to perform flow cytometry determinations. The death kinetics of Jurkat cells challenged with 7BIO was found to reproduce that of SH-SY5Y (Fig. 3A) . Dead cells began to appear between 3 and 6 hours of treatment. After 12 hours, almost all the cell membranes had lost their impermeability. The process in Jurkat cells was also independent of caspases, as evidenced by the null effect of Q-VD-Oph on cell death ratios (Fig. 3B) . Upon a 7BIO treatment and electron microscopy, Jurkat cells displayed a morphological pattern of cell death identical to the one just reported in SH-SY5Y cells. Four additional cell lines (HL-60, MCF-7, IMR-5 and IMR-32) were also characterized and reproduced this death pattern when treated with 7BIO (not shown). 12 The previous morphological studies suggested 7BIO was causing an early effect on mitochondria. This fact and the central role of mitochondria in many cell death processes, prompted us to explore the involvement of this organelle in 7BIO deadly effects. The dilation of mitochondria has been correlated with the loss of mitochondrial membrane potential (∆Ψm), therefore we characterized this parameter by means of the DiOC6(3) fluorochrome and flow cytometry. DiOC6(3) is a membrane-permeable reagent that accumulates in healthy mitochondria displaying physiological values of ∆Ψm. The reduction ∆Ψm implies a decrease of the cell fluorescence. A decreased fluorescence was found after a treatment with 7BIO (25 µM) for 9 hours, either in SH-SY5Y or in Jurkat cells (Fig. 4A ).
7BIO-induced cell death and the decrease of ∆Ψm is not mediated by either Bax or Bak proteins
In the apoptotic models of cell death, mitochondrial damage is mediated by the proapoptotic members of the Bcl-2 family of proteins, essentially Bax and Bak. We wondered what the lethality of 7BIO would be if tested on cells not expressing Bax and Bak proteins. Therefore, we proceeded to compare the effects of 7BIO on mouse embryonic fibroblasts (MEFs), either w.t. or double Bax-/-Bak-/-. The MTS reduction procedure was employed to determine the percentage of cell viability (not shown). The LDH release procedure was used to quantify the percentages of cell death (Fig. 4B) . Both approaches yielded consistent and complementary results. Precisely, 7BIO was inducing the death of both types of MEFs in the same range of concentrations and in a concentration-dependent manner. Consequently, the absence of Bax and Bak proteins did not confer any cell resistance to the 7BIO compound. On the other hand, as expected from cells defective in Bax and Bak, Stauroporine (STS) was not able to trigger apoptosis in these cells. Next, we explored the effects of double Bax/Bak deficiency on ∆Ψm dissipation by 7BIO (Fig. 4C) .
The result was that ∆Ψm collapsed only after 3 hours of treatment and double Bax/Bak deficiency was neither minimizing nor significantly delaying the collapse. Finally, we were concerned about the null expression of Bax and Bak modifying the death phenotype caused by 7BIO. Consequently, we decided to perform electron microscopy studies on w.t. and double Bax-/-Bak-/-MEFs under 7BIO treatment (Fig. 5) .
The progressive dilation of the endoplasmic reticulum leading to cytoplasm disintegration and cell death 13 was detected in both types of MEFs. In conclusion, Bax and Bak proteins were not required for 7BIO to kill the cells.
7BIO-induced loss of ∆Ψm was not counteracted by inhibitors of the MPTP
Once Bax and Bak protein were discarded as elements mediating 7BIO effects on cell viability and ∆Ψm, we focused on the role played by the mitochondrial permeability transition pore (MPTP). The adenosine nucleotide translocator (ANT) is the inner mitochondrial component of the channel regulating ∆Ψm.
Bongkrekic acid (BKKA) is a chemical agent able to block ANT opening and to counteract ∆Ψm loss [19] .
Similarly, by acting on ANT-associated cyclophilin D, Cyclosporin A (CsA) is able to neutralize ANTmediated ∆Ψm loss [20] . The protective effect of both compounds was assayed on SH-SY5Y and Jurkat cells challenged with 7BIO. We found no rescue effect either on cell death or on ∆Ψm dissipation by the presence of either 50 µM BKKA or 2 µM CsA in the culture medium (Fig. 6) . Next, we thought of the possibility that 7BIO could have a double mode of action consisting of Bax and/or Bak activation plus MPTP opening. This would mean one mechanism of ∆Ψm loss being able to compensate for the blockage of the other. This caveat led us to test the effects of BKKA and CsA on double Bax-/-Bak-/-MEFs (Fig. 7 ).
Moreover, we tested BKKA plus CsA added together on Bax-/-Bak-/-MEFs facing 7BIO (not shown). In all experimental conditions, neither cell death nor ∆Ψm loss was meaningfully reduced. In conclusion, MPTPinhibiting agents were not able to antagonize 7BIO-induced ∆Ψm collapse and the null role of Bax and Bak proteins was further reinforced.
Neither AIF translocation nor DNA degradation were detected in cells treated with 7BIO
AIF (Apoptosis Inducing Factor) is a flavoprotein that is located in the mitochondria and which functional activity is characterized by being double and opposed [21] . If placed at the mitochondrial inner membrane, AIF displays cytoprotective actions. Upon mitochondrial outer membrane permeabilization, its translocation seems to be responsible for many of the caspase-independent traits of apoptosis. Consequently, we considered mandatory to explore the putative involvement of AIF in the lethal effects of 7BIO. We proceeded to determine if AIF became present in the cytosol upon a treatment with 7BIO. SH-SY5Y (Fig.   8A ) and Jurkat (not shown) cells were fractioned as reported in the materials and methods section and the AIF content in the cytosolic and mitochondrial fractions was determined by Western Blot. As shown, AIF remained in the mitochondrial fraction along the dying process triggered by 7BIO. As a positive control of AIF translocation, we used the apoptosis-inducing 5BIO compound. As expected, 5BIO caused AIF release from mitochondria in the cells undergoing apoptosis. In addition, we explored the degradation of cell chromatin (Fig. 8B) . 5BIO treatment caused the apoptotic laddering of DNA while 7BIO was not producing this low molecular weight type of chromatin degradation, in agreement with a previous report [14] . Next we studied the high molecular weight fragmentation of chromatin, which was clearly observed in cells treated with 5BIO but absent from 7BIO-treated ones. In conclusion, these fragmentation patterns are distinctive traits of apoptosis but are not found in 7BIO-induced cell death. Moreover, the overall integrity of DNA is consistent with the preserved morphology of nuclei and chromatin observed in the previous ultrastructural studies.
7BIO was not triggering calpain-or cathepsin-type protease activity
Calpain and cathepsin, like caspases, are cysteine proteases which activation has been implicated in the necrotic type of cell death [7, 8] . Therefore, we proceeded to analyze their involvement in the death process triggered by 7BIO. First we tested the effect of several pharmacological inhibitors of these enzymes on SH-SY5Y and Jurkat cells. Calpeptin is known to be an inhibitor of calpain and cathepsin L proteases. zFAfmk is an inhibitor of cathepsins B and L. Leupeptin inhibits cathepsins A and B among other cysteine plus serine proteases included in its spectrum. Finally, zVADfmk is a general inhibitor of caspases with the ability to inhibit other cysteine proteases, for instance calpains and cathepsins, at a concentration of 100 µM [22] . 15 The specific capase inhibitor Q-VD-Oph, that is unable to inhibit calpains and cathepsins, was used as a control. In a summary, the presence of these inhibitors did not change the ratios of cell lethality caused by 7BIO (Fig. 9A) . In addition, calpain activity was assessed directly by means of a fluorescence-releasing substrate (Fig. 9B) . The increase of calpain activity detected in SH-SY5Y cells challenged with 7BIO was negligible. Cathepsin activation was also checked by an analogous approach in Jurkat cells treated with 7BIO (Fig. 9C) . While 5BIO treatment activated cathepsins significantly, 7BIO displayed activation values undistinguishable from untreated cells. In conclusion, neither calpains nor cathepsins seemed engaged in the 7BIO mode of action.
The activity of serine proteases was involved in 7BIO-induced cell death
In order to find a molecular event actively involved in the 7BIO mechanism of cell killing, we decided to perform a broad pharmacological screening. We searched for a compound or family of compounds with the ability to revert the death process, either stopping or significantly delaying it. Based on the results described before, 9 hours was considered the optimal time point for the detection of a putative protective effect. The SH-SY5Y cells and the MTS procedure were chosen to perform the screening. Substances able to prevent cell oxidative stress or calcium overload, like N-Acetylcysteine, Nifedipine, BAPTA AM and Ruthenium Red were combined with 7BIO, but did not modify the cell death process. Proteasome inhibitors like Lactacystin and Bortezomib were also tested and did not reverse 7BIO lethality. Finally, 3-methyladenine and necrostatin-1, as pharmacological inhibitors of autophagy [23] and necroptosis [24] respectively, failed to antagonize 7BIO toxicity (not shown). Among all the chemicals tested, some serine protease inhibitors were those with the most remarkable ability to block the cell death process in both, SH-SY5Y and Jurkat cell lines (Fig. 10A) . These compounds are chemically unrelated and share the property of inhibiting serine proteases. Therefore, the involvement of a serine protease activity, which is inhibited by TPCK, DCI and, particularly, the AEBSF compound but not TLCK, was concluded.
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AEBSF continued to protect the cells from 7BIO after 24 hours of treatment, although to a lesser extent than at 9 hours (not shown). When times longer than 24 hours were analyzed, AEBSF intrinsic lethality impaired any solid conclusion (not shown). To better characterize the AEBSF protective effect, we determined ∆Ψm in Jurkat cells challenged with 7BIO and 7BIO plus AEBSF (Fig. 10B) . These experiments revealed ∆Ψm loss as soon as 2 hours after 7BIO treatment, thus indicating again a very initial mitochondrial injury. Furthermore, AEBSF was clearly demonstrating a protective effect on mitochondria. In conclusion, we propose the involvement of the proteolytic activity of at least one, yet undetermined, serine protease in the 7BIO mode of action.
Discussion
The new indirubin derivative 7BIO has demonstrated to be a fast and efficient cell killer in all the cell lines we have tested so far. The death process is characterized by being caspase-independent and, accordingly, not to show apoptotic features like typical nuclear condensation plus fragmentation, DNA laddering or cytochrome c translocation to the cytoplasm. In addition, we have proved the process not to be mediated by p53 and to be insensitive to either Bcl-2 or Bcl-XL proteins [14] . In this report we have attempted to gain insight into the cell death process caused by 7BIO. Electron microscopy provided evidence of an identical morphological pattern, irrespective of the cell type studied. The pattern consisted of early mitochondrial swelling and cristae disruption, progressive dilation of the endoplasmic reticulum and final destruction of the cytoplasm yielding isolated nuclei with a remarkable preserved structure. Though a diffuse increase in chromatin condensation could be observed, it was different from the peripheral, AIF-mediated stage-1 type [25] . In agreement, a kinetic analysis of AIF protein translocation ruled out AIF participation. Moreover, the release of AIF from mitochondria is known to require either calpain or cathepsin activation [22, 26] .
Consistently, neither calpain nor cathepsin protease activity was triggered in cells by the 7BIO action.
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The observation of injured mitochondria early in the death process prompted us to focus on ∆Ψm disruption, as a representative parameter of the mitochondrial function. In Jurkat cells we found ∆Ψm decreased as soon as 2 hours following 7BIO treatment. This was in accordance with the timing observed for the morphological disruption of mitochondria. The collapse of ∆Ψm can be caused by either Bax/Bak protein activation or the MPTP opening [27] . Therefore, double Bax-/-Bak-/-MEFs were studied and a null involvement of both proteins was found. CsA and BKKA are two chemical agents with the ability to block the opening of the ANT component of the MPTP [19, 20] . Neither was able to prevent cell death or ∆Ψm disruption in the four cell lines tested, SH-SY5Y, Jurkat, w.t. and double Bax-/-Bak-/-MEFs. The fact that CsA and BKKA acting on Bax-/-Bak-/-MEFs made no difference, allowed to discard 7BIO might simultaneously act on two different targets Bax/Bak proteins and the MPTP. However, in relation to MPTP involvement, nothing could be definitively concluded. Even though the reversion of ∆Ψm disruption by CsA and BKKA suggests the involvement of the MPTP, a negative result cannot be interpreted as proving its non-involvement. MPTP could be activated by a yet undiscovered mechanism triggered by 7BIO and insensitive to the effects of CsA and BKKA. For example, a hypothetical mechanism not mediated by ANT, the target of both CsA and BKKA. In addition, the possibility of an MPTP-independent mechanism could be envisaged as the cause of ∆Ψm disruption.
What is the molecular target for 7BIO? The bis-indole structure of 7BIO suggests an ATP competing action and, therefore, protein kinases are the first target candidates. However, up to date, 85 protein kinases have been studied and discarded as responsible for this type of cell death [14] . Alternatively, we are thinking of exploring the elements constituting the mitochondrial respiratory chain as possible targets. The disruption of mitochondrial respiration is a good hypothesis for an MPTP-independent mechanism to disrupt ∆Ψm. On the other hand, in 7BIO triggered cell death, we have identified the involvement of a protease activity which is characterized by its sensitivity to serine protease inhibitors and, particularly, to AEBSF.
AEBSF is a chemical inhibitor of serine proteases and several apoptotic features are known to be 18 neutralized by this compound [28, 29] . Long ago, we described the ability of TLCK, a trypsin-like protease inhibitor, to inhibit cycloheximide-induced cell death in N18, a mouse neuroblastoma cell line [30] .
Interestingly, N18 cells underwent an unusual vacuolated type of apoptosis facing the inhibition of new protein synthesis with cycloheximide. Other authors have identified TLCK sensitive serine proteases in apoptosis and named them serpases [31] . However, none of these reports were dealing with a necrotic type of cell death like the one triggered by 7BIO. Moreover, our results show no involvement of a TLCK sensitive, trypsin-like, serine protease and, instead, point to a TPCK sensitive, chymotrypsin-like, one. Such an activity has been described in the proteasome and DCI compound is known to be a proteasome inhibitor at the concentration we have used. Since specific inhibitors of the proteasome did not modify 7BIO-induced lethality, we do not support a role for proteasome activation in the 7BIO mode of action.
There is a general agreement not to create a plethora of names to identify processes of cell death with specific features [3] . For instance, we were very cautious not to propose a name for an atypical cell death process that ended up being a defective type of apoptosis caused by the absence of CAD, the Caspase-Activated DNAse protein [32] . Concerning 7BIO-triggered death process, we propose to consider it a specific type of necrosis. Based on this report results and those previously published [14] , we believe there is sufficient evidence to no longer suspect that 7BIO-type of cell death is a defective phenotype of apoptosis. Is it autophagic cell death? Indeed, autophagy has been observed in the cell corpses but its role in causing cell death is doubtful. First, autophagy seems not to be present in most cells. Second, in 7BIO challenged cells, we have assayed 3-methyladenine at concentrations able to block autophagy [23] . Neither a rescue nor a deleterious effect was found. Third, Bcl-2 is known to prevent autophagic cell death by it ability to neutralize the protein Beclin [33] . We have reported the null effect of Bcl-2 overfunction on the 7BIO lethal effects [14] . These facts strongly support our doubts about autophagy being the 7BIO mode of cell killing. Autophagy has been defined as a cell death process not necessarily caused by autophagy but with autophagy being present [3] . Based on this definition, we could define as autophagic the cell death 19 process triggered by 7BIO. However, we do not favor this option. First, as just mentioned, autopahgy seems not to affect the entire cell population. Second, we believe the nomenclature of a cell death type should be as informative as possible about the mechanisms leading to it. In conclusion, we prefer to maintain the term necrosis (Type III cell death) to define the 7BIO-induced death process.
Recently, a lot of interest has been raised by several paradigms of necrosis as molecularly regulated processes of cell death. In these paradigms, cyclophilin D, calpains and cathepsins are expected to have a determinant role [7] [8] [9] [10] However, in the present report, their involvement has been ruled out.
Furthermore, the lack of cathepsin activation precludes the involvement of the lysosomes and a lysosomaltype cell death. The cell ultrastructure caused by 7BIO evoked a cell death process observed in embryonic development and named cytoplasmic type [2] . However, any relationship with the 7BIO induced death process is merely speculative. Unless the embryonic process can be transferred, for example, to cell culturing conditions to allow molecular analyses, it will be very difficult to find a potential correlate. This is why we have not used cytoplasm disintegration or cytoplasmic type as a very suitable nomenclature for the 7BIO-induced cell death. Several models of atypical cell death have been described so far. Paraptosis is characterized by caspase 9 activation and a late occurrence of mitochondria swelling [34] , therefore it is clearly different from the 7BIO-trigered process. Necroptosis displays distinctive features of necrosis and autophagy very similar to the ones we have described here [24] . The death preventive effect of necrostatin- 
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